Berkshire Hathaway’s GSK GSK Stock Holding History

Berkshire Hathaway’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-276,655	Closed	-$17.4M	–	44
2013 Q3	$17.4M	Sell	276,655 -904,162	-77%	-$58.2M	0.02%	39
2013 Q2	$73.8M	Buy	+1,180,817	New	+$74.9M	0.08%	35

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Berkshire Hathaway's GSK Position: Q4 2013 in Review

Berkshire Hathaway sold out of GSK (GSK) in Q4 2013, closing a stake of 276,655 shares — an estimated $17.4M sold.

Berkshire Hathaway first reported a position in GSK in Q2 2013 and held it in 2 quarters. The position peaked at $73.8M in Q2 2013. 681 funds tracked by Wall St. Rank hold GSK as of Q4 2013.

Berkshire Hathaway reported no remaining GSK position as of Q4 2013 after selling out during the quarter.
Berkshire Hathaway sold 276,655 GSK shares in Q4 2013, an estimated $17.4M.
Berkshire Hathaway first reported a position in GSK in Q2 2013 and held it in 2 quarters.
Berkshire Hathaway's GSK position peaked at $73.8M in Q2 2013.
681 funds tracked by Wall St. Rank held GSK as of Q4 2013.

Based on Berkshire Hathaway's 13F filing for Q4 2013, filed 14 Feb 2014.